Neema Ngugi: Understanding the D-Dimer Test – A Key Tool in Detecting Blood Clots
Neema Ngugi, Nephrology Nurse Nephrology at The Nairobi South Hospital, shared a post on LinkedIn:
“Understanding the D-Dimer Test: A Key Tool in Detecting Blood Clots
The D-Dimer test plays a crucial role in clinical decision-making, especially when evaluating patients for suspected thrombotic events.
It measures fibrin degradation products – essentially fragments produced when a blood clot dissolves in the body.
Why is it done?
Primarily, the D-Dimer test is used to rule out serious clotting conditions such as:
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Disseminated Intravascular Coagulation (DIC)
- Stroke or Myocardial Infarction
How to interpret results?
- Normal D-Dimer – Clotting is unlikely
- Elevated D-Dimer – Not diagnostic, but signals the need for further investigation (e.g., imaging studies)
Important to remember:
An elevated D-Dimer is not specific.
Levels can also rise in conditions such as:
- Infection
- Pregnancy
- Recent surgery
- Liver disease
- Cancer
Clinical takeaway:
The D-Dimer test is most powerful when used appropriately – especially in low to moderate-risk patients – to safely exclude life-threatening clotting conditions and avoid unnecessary imaging.
As healthcare professionals, understanding when and how to use this test ensures accurate diagnosis, timely intervention, and improved patient outcomes.”
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 30, 2026, 15:38Ahvie Herskowitz: Is It Iron or ‘Oxidized Rust’? – A New Predictor of Aging.
-
Apr 30, 2026, 15:01Neil Morgan: New Collaborative Research Review on Large‐Scale Genetic Analysis in the Bleeding Disorders Community
-
Apr 30, 2026, 14:33Abdul Mannan: The Clinical Pattern That Should Make You Think of VEXAS
-
Apr 30, 2026, 14:28Jennifer Le Mac: How the Immune System Shapes Venous Thrombosis
-
Apr 30, 2026, 14:22Samantha Xavier: Successfully Defended My PhD Thesis on P-Selectin as a Biomarker for Venous Thromboembolism
-
Apr 30, 2026, 14:09Robert Lufkin: Anti-Amyloid Drugs Fail Alzheimer’s Patients
-
Apr 30, 2026, 13:54Matthew D. Neal: A Major Step Forward in Trauma and Resuscitation Science
-
Apr 30, 2026, 13:35Day 2 of the EHC Youth Leadership Workshop 2026
-
Apr 30, 2026, 13:23The Gap Between Clinical Assessment and Patient Experience in VTE – RPTH Journal